Piotr Jakubowski
Chief Executive Officer bei COPERNICUS SECURITIES S.A.
Profil
Piotr Jakubowski is currently the Chairman of the Management Board at Copernicus Securities SA. He is also the Deputy Chairman of the Supervisory Board at Emmerson Realty SA since 2018.
Additionally, he serves as a Member of the Supervisory Board at Erne Ventures SA and is a Member of The Polish Society of Market & Opinion Researchers.
Mr. Jakubowski previously held positions as the Chairman of the Supervisory Board at Grupa Emmerson SA, a Member of the Supervisory Board at InteliWISE SA, and a Member of the Supervisory Board at B2BPartner SA. He obtained his undergraduate degree from the Warsaw School of Economics.
Aktive Positionen von Piotr Jakubowski
| Unternehmen | Position | Beginn |
|---|---|---|
| ERNE VENTURES SA | Director/Board Member | 21.07.2010 |
| EMMERSON REALTY S.A. | Director/Board Member | 24.12.2010 |
| COPERNICUS SECURITIES S.A. | Chief Executive Officer | - |
| The Polish Society of Market & Opinion Researchers | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Piotr Jakubowski
| Unternehmen | Position | Ende |
|---|---|---|
| GRUPA EMMERSON S.A. | Chairman | - |
| B2BPARTNER SA | Director/Board Member | - |
| INTELIWISE S.A. | Director/Board Member | - |
Ausbildung von Piotr Jakubowski
| Warsaw School of Economics | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| INTELIWISE S.A. | Technology Services |
| COPERNICUS SECURITIES S.A. | Finance |
| B2BPARTNER SA | Commercial Services |
| EMMERSON REALTY S.A. | Finance |
| Private Unternehmen | 3 |
|---|---|
Erne Ventures SA
 Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
Grupa Emmerson SA
 Grupa Emmerson SA Real Estate DevelopmentFinance Grupa Emmerson SA provides real estate brokerage services. It provides property management and consulting services including cleaning, maintenance, repairs, and financial administration to commercial and residential developments as well as individuals. The company was founded by Marek Krajewski in 1994 and is headquartered in Warsaw, Poland. | Finance |
| The Polish Society of Market & Opinion Researchers |
